Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge.
Serum cytokine profiles were evaluated in immunized and nonimmunized human volunteers after challenge with infectious Plasmodium falciparum sporozoites. Three volunteers had been immunized with x-irradiated sporozoites and were fully protected from infection. Four nonimmune volunteers all developed symptomatic infection at which time they were treated. Sera from all volunteers were collected at approximately 20 time points during the 28-d challenge period; levels of IL-1 alpha, IL-1 beta, IL-2, IFN-gamma, tumor necrosis factor-alpha, IL-4, IL-6, granulocyte macrophage-colony-stimulating factor, and soluble CD4, CD8, and IL-2 receptor (sCD4, sCD8, and sIL-2R, respectively) were determined by ELISA. C-reactive protein (CRP) was assayed by radial immunodiffusion. Parasitemic subjects developed increases in CRP and IFN-gamma, with less marked increases in sIL-2R and sCD8; the other cytokines tested did not change. CRP increases were abrupt and occurred at the onset of fever (day 14 after challenge). IFN-gamma increases were also abrupt, preceding those of fever and CRP by one day. Increases in sIL-2R and sCD8 were more gradual. Increases in fever, CRP, IFN-gamma, and sCD8 were concordant in each volunteer. Early IL-6 increases were noted in the protected vaccinees. Thus, after challenge with virulent P. falciparum, unique systemic cytokine profiles were detectable both in immunized, nonparasitemic volunteers and in unvaccinated, parasitemic subjects. The contrasting cytokine profiles in the two groups may relate to mechanisms of protection and immunopathology in experimental human malaria.
Harpaz
R
R
Department of Medicine, University of Maryland School of Medicine, Baltimore 21201.
Edelman
R
R
Wasserman
S S
SS
Levine
M M
MM
Davis
J R
JR
Sztein
M B
MB
D000818:Animals; D002097:C-Reactive Protein / Q000378:metabolism; D016827:CD8 Antigens / Q000097:blood; D016207:Cytokines / Q000097:blood*; D006801:Humans; D007114:Immunization; D007371:Interferon-gamma / Q000097:blood; D015847:Interleukin-4 / Q000097:blood; D015850:Interleukin-6 / Q000097:blood; D016778:Malaria, Falciparum / Q000097:blood* / Q000517:prevention & control; D008297:Male; D010963:Plasmodium falciparum / Q000276:immunology; D015375:Receptors, Interleukin-2 / Q000737:chemistry / Q000378:metabolism; D012995:Solubility; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D016827:CD8 Antigens; D016207:Cytokines; D015850:Interleukin-6; D015375:Receptors, Interleukin-2; D014409:Tumor Necrosis Factor-alpha; D015847:Interleukin-4; D007371:Interferon-gamma; D002097:C-Reactive Protein